|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.50 EUR | -3.81% |
|
-5.94% | -12.28% |
| Dec. 15 | BofA maintains its buy rating on Eramet, with a target price of €64 |  |
| Dec. 09 | Oddo BHF Maintains Negative Stance on Eramet Despite Raised Target | |
| Capitalization | 1.35B 1.59B 1.26B 1.18B 2.18B 144B 2.39B 14.72B 5.68B 67.74B 5.95B 5.83B 246B | P/E ratio 2025 * |
-4.92x | P/E ratio 2026 * | -12.6x |
|---|---|---|---|---|---|
| Enterprise value | 3.08B 3.62B 2.88B 2.7B 4.98B 329B 5.46B 33.64B 12.98B 155B 13.59B 13.31B 561B | EV / Sales 2025 * |
1.03x | EV / Sales 2026 * | 0.91x |
| Free-Float |
28.55% | Yield 2025 * |
3.16% | Yield 2026 * | 2.84% |
Last Transcript: Eramet
| 1 day | -3.81% | ||
| 1 week | -5.94% | ||
| Current month | -11.38% | ||
| 1 month | -12.92% | ||
| 3 months | -7.77% | ||
| 6 months | +2.95% | ||
| Current year | -12.28% |
| 1 week | 47.5 |  | 55.2 |
| 1 month | 47.5 | | 55.45 |
| Current year | 38.74 | | 66.7 |
| 1 year | 38.74 | | 66.7 |
| 3 years | 38.74 | | 114.5 |
| 5 years | 38.74 | | 166 |
| 10 years | 15.36 | | 167.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2025-05-25 | |
| Director of Finance/CFO | 54 | 2025-09-14 | |
| Chief Operating Officer | 58 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 2011-05-10 | |
| Director/Board Member | 69 | 2016-09-22 | |
| Director/Board Member | 58 | 2011-05-10 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.04% | 178 M€ | +25.58% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.81% | -5.94% | -9.09% | -39.57% | 1.65B | |
| +0.14% | -0.56% | +10.06% | -3.70% | 149B | |
| +0.55% | +2.44% | +16.98% | +0.91% | 129B | |
| -1.96% | -0.10% | +60.39% | +129.56% | 73.62B | |
| -1.89% | -3.47% | +9.31% | +31.22% | 60.04B | |
| -1.97% | -1.89% | +1.51% | -29.71% | 59.77B | |
| -0.49% | -2.67% | +2.59% | -19.37% | 41.19B | |
| +2.38% | +5.87% | +345.39% | +242.23% | 28.16B | |
| +2.19% | +13.35% | +18.41% | +79.45% | 26.46B | |
| +0.98% | +9.81% | +14.39% | +83.11% | 23.66B | |
| Average | -0.37% | +1.83% | +46.99% | +47.41% | 59.3B | |
| Weighted average by Cap. | -0.27% | +1.06% | +32.78% | +32.42% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.99B 3.52B 2.8B 2.62B 4.84B 320B 5.3B 32.67B 12.61B 150B 13.2B 12.93B 545B | 3.4B 4.01B 3.18B 2.98B 5.51B 364B 6.04B 37.19B 14.35B 171B 15.03B 14.72B 620B |
| Net income | -276M -325M -258M -242M -447M -29.57B -490M -3.02B -1.16B -13.89B -1.22B -1.19B -50.36B | -108M -127M -101M -94.68M -175M -11.56B -192M -1.18B -455M -5.43B -477M -467M -19.68B |
| Net Debt | 1.73B 2.04B 1.62B 1.52B 2.8B 185B 3.07B 18.92B 7.3B 87.05B 7.64B 7.49B 316B | 1.75B 2.06B 1.64B 1.53B 2.83B 187B 3.1B 19.1B 7.37B 87.92B 7.72B 7.56B 319B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 47.50 € | -3.81% | 97,847 |
| 25-12-15 | 49.38 € | -7.79% | 133,081 |
| 25-12-12 | 53.55 € | +3.48% | 71,494 |
| 25-12-11 | 51.75 € | +1.57% | 29,691 |
| 25-12-10 | 50.95 € | +0.89% | 27,186 |
Real-time Euronext Paris, December 16, 2025 at 11:55 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERA Stock
Select your edition
All financial news and data tailored to specific country editions
